Wall Street thinks this weight-loss drug stock could more than 3x over the next 12 ... Also, Viking was seen by some as a potential acquisition target for Merck. However, Merck announced in December ...
As high prices and supply issues drive consumers to alternative markets for GLP-1s, physicians aren’t too interested in using ...
The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback